|
NCT00215917
|
|
D-Serine Monotherapy for Schizophrenia
|
Phase 1/Phase 2
|
Recruiting
|
|
NCT02156908
|
2014-08-01 |
D-serine and Cognitive Remediation in Schizophrenia
|
Phase 2
|
Active, Not Recruiting
|
|
NCT01715051
|
2014-02-01 |
D-Serine for Cocaine Dependence Pilot
|
Phase 2
|
Withdrawn
|
|
NCT01733407
|
2013-09-01 |
L-Serine Supplementation in Hereditary Sensory Neuropathy Type 1
|
Phase 1/Phase 2
|
Active, Not Recruiting
|
|
NCT01835782
|
2013-01-01 |
Determining the Safety of L-serine in ALS
|
Phase 1/Phase 2
|
Recruiting
|
|
NCT01804920
|
2013-01-01 |
D-Serine Treatment For Tardive Dyskinesia
|
Phase 2/Phase 3
|
Recruiting
|
|
NCT01474395
|
2012-03-01 |
N-methyl-D-aspartic Acid (NMDA) and Cognitive Remediation in Schizophrenia
|
Phase 2
|
Recruiting
|
|
NCT01459029
|
2011-11-01 |
High Dose D-Serine as Adjuvant Treatment for Recent Onset Schizophrenia
|
Phase 2
|
Not Yet Recruiting
|
|
NCT01128244
|
2010-04-01 |
Vitamin B6 Effects for Women Taking Birth Control Pills
|
Phase 2/Phase 3
|
Completed
|
|
NCT01018056
|
2009-11-01 |
Developing New Treatments for Tourette Syndrome: Therapeutic Trials With Modulators of Glutamatergic Neurotransmission
|
Phase 4
|
Completed
|
|
NCT00817336
|
2009-06-01 |
Biomarkers in Schizophrenia
|
Phase 2
|
Completed
|
|
NCT00826202
|
2009-03-01 |
D-serine for the Schizophrenia Prodrome
|
Phase 2
|
Active, Not Recruiting
|
|
NCT00816894
|
2009-01-01 |
D-serine Monotherapy for Schizophrenia
|
Phase 2
|
Completed
|
|
NCT00499265
|
2007-04-01 |
Gemcitabine With or Without WX-671 in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery
|
Phase 2
|
Completed
|
|
NCT00322023
|
2006-03-01 |
Safety and Effectiveness of D-Serine in Schizophrenia
|
Phase 2
|
Active, Not Recruiting
|
|
NCT00243308
|
2005-10-01 |
Serp-1 for the Treatment of Acute Coronary Syndrome
|
Phase 2
|
Terminated
|
|
NCT00237848
|
2005-02-01 |
D-Serine for Enhancing Cognitive Retraining for the Treatment of Schizophrenia
|
Phase 3
|
Completed
|
|
NCT00491569
|
2005-01-01 |
Sarcosine or D-Serine Add-on Treatment for Chronic Schizophrenia
|
Phase 2
|
Completed
|
|
NCT00138775
|
2004-10-01 |
Israel Multicenter D-Serine Study (IMSER) for the Treatment of Schizophrenia
|
Phase 2
|
Recruiting
|
|
NCT00215904
|
2003-08-01 |
D-serine Adjuvant Treatment for Parkinson's Disease
|
Phase 4
|
Completed
|
|
NCT00215878
|
2003-08-01 |
D-serine for Posttraumatic Stress Disorder Treatment
|
Phase 2
|
Completed
|
|
NCT00237809
|
2002-09-01 |
D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia
|
Phase 3
|
Recruiting
|